It’s now approved for the treatment of moderate to severe eczema; ulcerative colitis; and ankylosing spondylitis. It’s already used for rheumatoid and psoriatic arthritis.
Informing consumers about its potential benefits has taken this pharmaceutical brand to viewers via a new Spot TV campaign — one that tops the latest Media Monitors report.
